I was diagnosed with advanced breast cancer that was Her2 positive. I was given two targeted therapy drugs along with chemotherapy. Today I am fortunate to have no disease. I do need to take the targeted therapies every three weeks but can not be grateful enough for...
Dr. Keighley Reisenauer is the Communications Director for Iylon. Keighley Reisenauer is a Postdoctoral Teaching Fellow at Baylor University and the Communications Specialist for Iylon. Keighley earned her PhD in 2021 under the guidance of Dr. Joseph Taube and her...
Dr. Sewanti Limaye, MD, MS Director of Precision Oncology Director of Clinical and Translational Oncology Research Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute Translational Research Institute (TRI) Mumbai, India Dr. Sewanti Limaye, MD,...
Tweets by...
